Standard Operating Procedures in Daily Clinical Routine

This study has been completed.
Sponsor:
Information provided by:
University of Schleswig-Holstein
ClinicalTrials.gov Identifier:
NCT00596128
First received: January 7, 2008
Last updated: June 4, 2008
Last verified: June 2008
  Purpose

Primary study endpoint: blood sugar values

Patients: Patients admitted to an ICU

5 steps:

  1. Routine treatment,
  2. Implementation of SOP for blood sugar monitoring and intervention,
  3. Education of intensive care nurses,
  4. 6 months free interval without further education or check-up of SOP implementation,
  5. Check of SOP implementation and clinical outcome concerning range of blood sugar

Condition Intervention
Blood Glucose
Behavioral: Implementation of SOP

Study Type: Interventional
Study Design: Endpoint Classification: Safety Study
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Treatment
Official Title: Does Implementation of a Standard Operating Procedure for Blood Sugar Control Into Daily Clinical Routine Improve Care of Patients

Resource links provided by NLM:


Further study details as provided by University of Schleswig-Holstein:

Primary Outcome Measures:
  • blood sugar range [ Time Frame: 4 times a day for total ICU stay ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • ICU length of stay [ Time Frame: After discharge from ICU ] [ Designated as safety issue: No ]

Enrollment: 800
Study Start Date: December 2006
Study Completion Date: April 2008
Primary Completion Date: April 2008 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
No Intervention: 1
Blood sugar monitoring and intervention as clinical routine, no SOP defined and implemented
Experimental: 2
Blood sugar monitoring after implementation of SOP
Behavioral: Implementation of SOP
SOP for blood sugar monitoring and intervention will be defined and ICU nurses will be educated to use this SOP in clinical routine
Other Name: Insulin

Detailed Description:

SOP for blood glucose monitoring and treatment was implemented on an intensive care unit. Staff was trained. After a free interval patient's outcome was monitored in terms of daily blood sugar profile prior implementation of SOP and after implementation+free interval of SOP.

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Patients admitted to an ICU

Exclusion Criteria:

  • Patient's or close relative's refusal
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00596128

Locations
Germany
Department of Anaesthesiology and Intensive Care Medicine, UK S-H Campus Kiel
Kiel, Schleswig-Holstein, Germany, 24105
Sponsors and Collaborators
University of Schleswig-Holstein
Investigators
Principal Investigator: jens Scholz, MD, Chair Department of Anaesthesiology and Intensive Care Medicine, UK S-H Campus Kiel, kiel, Germany
  More Information

No publications provided

Responsible Party: Jens Scholz, Department of Anaesthesiology, UK S-H Campus Kiel
ClinicalTrials.gov Identifier: NCT00596128     History of Changes
Other Study ID Numbers: UK-SH_Hanss_2008/01
Study First Received: January 7, 2008
Last Updated: June 4, 2008
Health Authority: Germany: Ethics Commission

Keywords provided by University of Schleswig-Holstein:
Blood glucose
Clinical pathways

ClinicalTrials.gov processed this record on October 01, 2014